Where does Nova Biomedical Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Nova Biomedical Corporation ranks #15,501 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Nova Biomedical Corporation hold?

Nova Biomedical Corporation holds 19 US utility patents granted between 2015 and 2025, spanning 13 technology areas.

What is Nova Biomedical Corporation's Innovation Score?

Nova Biomedical Corporation has an Innovation Score of 41.5 out of 100 (top 33% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Nova Biomedical Corporation focus on?

Nova Biomedical Corporation's top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 16 patents, ranking #956 of 7,863 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is Nova Biomedical Corporation's patent grant rate increasing or decreasing?

Nova Biomedical Corporation's recent grant velocity is -58% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Nova Biomedical Corporation's patents?

Nova Biomedical Corporation's patents average 15.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Nova Biomedical Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Nova Biomedical Corporation

USPTO PatentsView assignee record - 19 granted patents across 13 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Nova ranks #15,501 of 49,997 tracked US assignees by granted-patent volume, with 19 patents across 13 technology areas.

#15,501
of 49,997 US assignees by volume: Top 33%
by Innovation Score (41.5/100): 15.9
avg claims per patent: -58%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R15501 · US Corporation #15,501 · 19 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 19 grants
MID-PACK #15,501/49,997
PHOTO-FINISH Nivalis Therapeutics
CPC-FOCUS G01N · 13 areas
INNOV-PAR 41.5/100
CLAIMS-RICH 15.9 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -58% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nivalis Therapeutics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Nova’s 41.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.3 pts (25%) Velocity 8.9 pts (21%) Breadth 12.7 pts (31%) Claim depth 9.5 pts (23%)

Qualcomm Incorporated · highest

85
Nova Biomedical · this assignee

42
3D Lighting… · lowest

7

What this shows Nova's Innovation Score is 41.5/100 (top 33% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Nova?

Each dot is one of Nova’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Nova’s own 15.9 claims/patent is ABOVE the 15.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Nova vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Nova's grants concentrate

Nova Biomedical Corporation is a focused PatentsView assignee: 13 CPC subclasses with 84.2% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2018 (6 grants) versus a trough of 1 in 2021. By volume, Nova sits between Nivalis Therapeutics, Inc. and Olympia Lighting, Inc..

Nova's three-year grant acceleration

Nova Biomedical Corporation shows 4 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Nivalis Therapeut…

19
Nordex Energy Spa…

19
Norfolk Southern

19
Nostromo

19
Novel Crystal Tec…

19
Novoluto

19
Nuflare Technolog…

19
Olympia Lighting

19
Nova Biomedical ◀

19

What this shows Nova holds 19 patents at rank #15,504, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Nova

By rank, the assignees closest to #15,504 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Nova's primary technology class.

Nova's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 33% higher than 67% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Nova Biomedical Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	10.5%
2017	2	10.5%
2018	6	31.6%
2019	2	10.5%
2021	1	5.3%
2022	2	10.5%
2023	1	5.3%
2024	1	5.3%
2025partial year	2	10.5%

Which technologies does Nova Biomedical Corporation patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 16

A61B - DIAGNOSIS; SURGERY; Identification 8

G01J - Measurement OF Intensity, Velocity, Spectral Content, Polarisation, Phase OR Pulse Characteristics OF Infrared, Visible OR Ultraviolet LIGHT; COLORIMETRY; Radiation Pyrometry 5

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 2

C08F - Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds 2

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

F04B - Positive-displacement Machines FOR LIQUIDS; Pumps 1

F04C - Rotary-piston, OR Oscillating-piston, Positive-displacement Machines FOR Liquids ; Rotary-piston, OR Oscillating-piston, Positive-displacement Pumps 1

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

C12Y - Enzymes 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Nova Biomedical Corporation's patent record in context - here's where to go next.

Nova Biomedical Corporation's lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 84.2% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #15,501 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Nova Biomedical Corporation against Nivalis Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.